Style | Citing Format |
---|---|
MLA | Sarabi Jamab M, et al.. "Is Narrow Band Imaging Accurate to Differentiate Between High-Risk and Low-Risk Vocal Fold Leukoplakia? a Systematic Review and Meta-Analysis." Oral Oncology Reports, vol. 11, no. , 2024, pp. -. |
APA | Sarabi Jamab M, Aghakouchakzadeh A, Keyhan SO, Rafiemanesh H, Mirzaei A, Teimouri Badeleh Dareh M (2024). Is Narrow Band Imaging Accurate to Differentiate Between High-Risk and Low-Risk Vocal Fold Leukoplakia? a Systematic Review and Meta-Analysis. Oral Oncology Reports, 11(), -. |
Chicago | Sarabi Jamab M, Aghakouchakzadeh A, Keyhan SO, Rafiemanesh H, Mirzaei A, Teimouri Badeleh Dareh M. "Is Narrow Band Imaging Accurate to Differentiate Between High-Risk and Low-Risk Vocal Fold Leukoplakia? a Systematic Review and Meta-Analysis." Oral Oncology Reports 11, no. (2024): -. |
Harvard | Sarabi Jamab M et al. (2024) 'Is Narrow Band Imaging Accurate to Differentiate Between High-Risk and Low-Risk Vocal Fold Leukoplakia? a Systematic Review and Meta-Analysis', Oral Oncology Reports, 11(), pp. -. |
Vancouver | Sarabi Jamab M, Aghakouchakzadeh A, Keyhan SO, Rafiemanesh H, Mirzaei A, Teimouri Badeleh Dareh M. Is Narrow Band Imaging Accurate to Differentiate Between High-Risk and Low-Risk Vocal Fold Leukoplakia? a Systematic Review and Meta-Analysis. Oral Oncology Reports. 2024;11():-. |
BibTex | @article{ author = {Sarabi Jamab M and Aghakouchakzadeh A and Keyhan SO and Rafiemanesh H and Mirzaei A and Teimouri Badeleh Dareh M}, title = {Is Narrow Band Imaging Accurate to Differentiate Between High-Risk and Low-Risk Vocal Fold Leukoplakia? a Systematic Review and Meta-Analysis}, journal = {Oral Oncology Reports}, volume = {11}, number = {}, pages = {-}, year = {2024} } |
RIS | TY - JOUR AU - Sarabi Jamab M AU - Aghakouchakzadeh A AU - Keyhan SO AU - Rafiemanesh H AU - Mirzaei A AU - Teimouri Badeleh Dareh M TI - Is Narrow Band Imaging Accurate to Differentiate Between High-Risk and Low-Risk Vocal Fold Leukoplakia? a Systematic Review and Meta-Analysis JO - Oral Oncology Reports VL - 11 IS - SP - EP - PY - 2024 ER - |